1 INDICATIONS AND USAGE
BOSULIF is indicated for the treatment of adult patients with:
- •
- Newly-diagnosed chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML).
- •
- Chronic phase, accelerated phase (AP), or blast phase (BP) Ph+ CML with resistance or intolerance to prior therapy.